1.
|
10 p, 772.3 KB |
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study
/
Drake, T. M. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Docherty, A. B. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Harrison, E. M. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Quint, J. K. (National Heart and Lung Institute. Imperial College) ;
Adamali, H. (Academic Respiratory Unit. University of Bristol. Southmead Hospital) ;
Agnew, Sarah (Liverpool Interstitial Lung Disease Service. Aintree site. Liverpool University Hospitals NHS Foundation Trust) ;
Babu, S. (Queen Alexandra Hospital (Portsmouth, Regne Unit)) ;
Barber, C. M. (Northern General Hospital) ;
Barratt, S. (Academic Respiratory Unit. University of Bristol. Southmead Hospital) ;
Bendstrup, Elisabeth (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Bianchi, S. (Northern General Hospital) ;
Castillo, Diego (Institut d'Investigació Biomèdica Sant Pau) ;
Chaudhuri, N. (University of Manchester) ;
Chua, F. (Royal Brompton and Harefield NHS Foundation Trust) ;
Coker, R. (Hammersmith Hospital (Londres)) ;
Chang, W. (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Crawshaw, A. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Crowley, L. E. (University of Birmingham) ;
Dosanjh, D. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Fiddler, C. A. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Forrest, I. A. (Department of Respiratory Medicine. Royal Victoria Infirmary. Newcastle upon Tyne Hospitals NHS Foundation Trust) ;
George, P. M. (Royal Brompton and Harefield NHS Foundation Trust) ;
Gibbons, M. A. (South West Peninsula ILD Network. Royal Devon & Exeter Foundation NHS Trust) ;
Groom, K. (Hammersmith Hospital (Londres)) ;
Haney, S. (Northumbria Specialist Emergency Care Hospital. Northumbria Healthcare NHS Foundation Trust) ;
Hart, S. P. (Respiratory Research Group. Hull York Medical School. Castle Hill Hospital) ;
Heiden, E. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Henry, M. (Cork University Hospital) ;
Ho, L. P. (Oxford Interstitial Lung Disease Service. Oxford University Hospitals NHS Foundation Trust) ;
Hoyles, R. K. (Oxford Interstitial Lung Disease Service. Oxford University Hospitals NHS Foundation Trust) ;
Hutchinson, J. (King's Mill Hospital) ;
Hurley, K. (Beaumont Hospital (Dublín, Irlanda)) ;
Jones, M. (National Institute for Health Research (NIHR). Southampton Biomedical Research Centre & Clinical and Experimental Sciences. University of Southampton) ;
Jones, S. (Action for Pulmonary Fibrosis. Stuart House) ;
Kokosi, M. (Guys and St. Thomas' NHS Trust) ;
Kreuter, M. (Center for Interstitial and Rare Lung Diseases. Pneumology. Thoraxklinik. University of Heidelberg. German Center for Lung Research) ;
MacKay, L. S. (Northumbria Specialist Emergency Care Hospital. Northumbria Healthcare NHS Foundation Trust) ;
Mahendran, S. (Kingston Hospital NHS Foundation Trust) ;
Margaritopoulos, G. (ILD Unit. Manchester University Hospital NHS Foundation Trust. Wythenshawe Hospital) ;
Molina Molina, Maria (Institut d'Investigació Biomèdica de Bellvitge) ;
Molyneaux, P. L. (National Heart and Lung Institute. Imperial College) ;
O'Brien, A. (University Hospital Limerick) ;
O'Reilly, K. (Department of Respiratory Medicine. Mater Misericordiae University Hospital) ;
Packham, A. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Parfrey, H. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Poletti, V. (Department of Diseases of the Thorax. Morgagni Hospital) ;
Porter, J. C. (UCL Respiratory. University College London. ILD Service. University College London Hospitals NHS Foundation Trust) ;
Renzoni, E. (Royal Brompton and Harefield NHS Foundation Trust) ;
Rivera-Ortega, P. (ILD Unit. Manchester University Hospital NHS Foundation Trust. Wythenshawe Hospital) ;
Russell, A. M. (Imperial Healthcare NHS Trust. St. Mary's Hospital. The Bays) ;
Saini, G. (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Spencer, L. G. (Liverpool Interstitial Lung Disease Service. Aintree site. Liverpool University Hospitals NHS Foundation Trust) ;
Stella, G. M. (Laboratory of Biochemistry and Genetics. Pneumology Unit. Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo) ;
Stone, H. (University Hospital North Midlands NHS Trust. Royal Stoke University Hospital) ;
Sturney, S. (Royal United Hospitals Bath NHS Foundation Trust) ;
Thickett, D. (University of Birmingham) ;
Thillai, M. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Wallis, T. (National Institute for Health Research (NIHR). Southampton Biomedical Research Centre & Clinical and Experimental Sciences. University of Southampton) ;
Ward, K. (National Heart and Lung Institute. Imperial College) ;
Wells, A. U. (Royal Brompton and Harefield NHS Foundation Trust) ;
West, A. (Guys and St. Thomas' NHS Trust) ;
Wickremasinghe, M. (Imperial Healthcare NHS Trust. St. Mary's Hospital. The Bays) ;
Woodhead, F. (Institute of Lung Health. Interstitial Lung Disease Unit. Glenfield Hospital) ;
Hearson, G. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Howard, L. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Baillie, John Kenneth (Intensive Care Unit. Royal Infirmary Edinburgh) ;
Openshaw, Peter (National Heart and Lung Institute. Imperial College) ;
Semple, M. G. (Respiratory Medicine. Alder Hey Children's Hospital) ;
Stewart, I. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Jenkins, R. G. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Universitat Autònoma de Barcelona
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population. [...]
2020 - 10.1164/rccm.202007-2794OC
American Journal of Respiratory and Critical Care Medicine, Vol. 202 Núm. 12 (15 2020) , p. 1656-1665
|
|